Research recommendation(s) from an individual piece of guidance
- Guidance:
- Anaphylaxis: assessment and referral after emergency treatment
- Date issued:
Research recommendations coming out of this guidance
- Mediators of anaphylactic reactions:- Aside from mast cell tryptase, which other chemical inflammatory mediators offer potential as indicators of anaphylaxis?
-
Aside from mast cell tryptase, which other chemical inflammatory mediators offer potential as indicators of anaphylaxis?
- The frequency and effects of biphasic reactions:- What are the frequency, timing, severity and predictors of biphasic reactions in people who have received emergency treatment for anaphylaxis?
-
What are the frequency, timing, severity and predictors of biphasic reactions in people who have received emergency treatment for anaphylaxis?
- Length of observation period following emergency treatment for anaphylaxis:- For how long should a person who has received emergency treatment for anaphylaxis be observed?
-
For how long should a person who has received emergency treatment for anaphylaxis be observed?
- Prevalence of anaphylactic reactions and related outcomes:- What is the annual incidence of anaphylaxis and its related outcomes within the UK?
-
What is the annual incidence of anaphylaxis and its related outcomes within the UK?
- Effect of specialist services on health-related quality of life:- For people who have experienced suspected anaphylaxis, what is the effect on health-related quality of life of (a) referral to specialist allergy services and (b) provision of adrenaline injectors, when compared with emergency treatment alone?
-
For people who have experienced suspected anaphylaxis, what is the effect on health-related quality of life of (a) referral to specialist allergy services and (b) provision of adrenaline injectors, when compared with emergency treatment alone?